Table:
0
A
B
C
D
E
F
1
Antibody
Brand name
Approval date
Type
Target
Approved treatment(s)
2
Alemtuzumab
Campath
2001
humanized
CD52
Chronic lymphocytic leukemia
3
Bevacizumab
Avastin
2004
humanized
vascular endothelial growth factor
colorectal cancer
4
Brentuximab vedotin
Adcetris
2011
chimeric
CD30
Hodgkin lymphoma , Anaplastic large-cell lymphoma
5
Cetuximab
Erbitux
2004
chimeric
epidermal growth factor receptor
colorectal cancer
6
Gemtuzumab ozogamicin
Mylotarg
2000
humanized
CD33
acute myelogenous leukemia (with calicheamicin )
7
Panitumumab
Vectibix
2006
human
epidermal growth factor receptor
colorectal cancer
8
Rituximab
Rituxan, Mabthera
1997
chimeric
CD20
non-Hodgkin lymphoma

Questions and formulas:
Question: What are all the approved treatments for the target CD30?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:F1,E1="CD30"),6))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:F8,E2:E8="CD30"),6))
Level: medium
Question: What is the brand name for the antibody Brentuximab Vedotin?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:F1,A1="Brentuximab vedotin"),2))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:F8,A2:A8="Brentuximab vedotin"),2))
Level: medium
Question: How many targets are there with an approval date of 1997?
Formula: ROWS(UNIQUE(FILTER(E1, C1=1997)))
Formula2: ROWS(UNIQUE(FILTER(E2:E8, C2:C8=1997)))
Level: medium
Question: What are the approved treatments when the antibody is bevacizumab?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:F1,A1="Bevacizumab"),6))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:F8,A2:A8="Bevacizumab"),6))
Level: medium
Question: What is the target when the approved treatment is non-hodgkin lymphoma?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:F1,F1="non-Hodgkin lymphoma"),5))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:F8,F2:F8="non-Hodgkin lymphoma"),5))
Level: medium
Question: What is the target with an approval date of 2006?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:F1,C1=2006),5))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:F8,C2:C8=2006),5))
Level: medium